Hochschulschrift
Modulation of prolyl hydroxylase domain (PHD) 2 in tumor inflammation
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Maße
-
30 cm
- Umfang
-
I, 62, V S.
- Sprache
-
Englisch
- Anmerkungen
-
Ill., graph. Darst.
Dresden, Techn. Univ., Diss., 2012
- Klassifikation
-
Medizin, Gesundheit
- Urheber
-
Soulafa, Mamlouk
- Inhaltsverzeichnis
- Rechteinformation
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Letzte Aktualisierung
-
11.06.2025, 14:08 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
- Soulafa, Mamlouk
Ähnliche Objekte (12)
Structural Basis of Prolyl Hydroxylase Domain Inhibition by Molidustat
Whole-Body Prolyl Hydroxylase Domain (PHD) 3 Deficiency Increased Plasma Lipids and Hematocrit Without Impacting Plaque Size in Low-Density Lipoprotein Receptor Knockout Mice
Prolyl hydroxylase domain 2 protein is a strong prognostic marker in human gastric cancer
Structure‐Activity Relationship and Crystallographic Studies on 4‐Hydroxypyrimidine HIF Prolyl Hydroxylase Domain Inhibitors
Use of cyclic peptides to induce crystallization: case study with prolyl hydroxylase domain 2
Prolyl-3-hydroxylase 1 in idiopathic pulmonary fibrosis
Cardiac functions of the cellular oxygen sensors prolyl-4-hydroxylase domain enzymes 2 and 3
The role of hif prolyl hydroxylases (PHD-2 and PHD-4) in tumor progression
Prolyl hydroxylase inhibition prevents graft injury during liver transplantation
Molecular exploration of natural and synthetic compounds databases for promising hypoxia inducible factor (HIF) Prolyl-4- hydroxylase domain (PHD) inhibitors using molecular simulation and free energy calculations
Prolyl hydroxylase domain inhibitor is an effective pre-hospital pharmaceutical intervention for trauma and hemorrhagic shock
Effect of prolyl hydroxylase domain 2 haplodeficiency on liver progenitor cell characteristics in early mouse hepatocarcinogenesis
Structural Basis of Prolyl Hydroxylase Domain Inhibition by Molidustat
Whole-Body Prolyl Hydroxylase Domain (PHD) 3 Deficiency Increased Plasma Lipids and Hematocrit Without Impacting Plaque Size in Low-Density Lipoprotein Receptor Knockout Mice
Prolyl hydroxylase domain 2 protein is a strong prognostic marker in human gastric cancer
Structure‐Activity Relationship and Crystallographic Studies on 4‐Hydroxypyrimidine HIF Prolyl Hydroxylase Domain Inhibitors
Use of cyclic peptides to induce crystallization: case study with prolyl hydroxylase domain 2
Prolyl-3-hydroxylase 1 in idiopathic pulmonary fibrosis
Cardiac functions of the cellular oxygen sensors prolyl-4-hydroxylase domain enzymes 2 and 3
The role of hif prolyl hydroxylases (PHD-2 and PHD-4) in tumor progression
Prolyl hydroxylase inhibition prevents graft injury during liver transplantation
Molecular exploration of natural and synthetic compounds databases for promising hypoxia inducible factor (HIF) Prolyl-4- hydroxylase domain (PHD) inhibitors using molecular simulation and free energy calculations
Prolyl hydroxylase domain inhibitor is an effective pre-hospital pharmaceutical intervention for trauma and hemorrhagic shock
Effect of prolyl hydroxylase domain 2 haplodeficiency on liver progenitor cell characteristics in early mouse hepatocarcinogenesis
Structural Basis of Prolyl Hydroxylase Domain Inhibition by Molidustat
Whole-Body Prolyl Hydroxylase Domain (PHD) 3 Deficiency Increased Plasma Lipids and Hematocrit Without Impacting Plaque Size in Low-Density Lipoprotein Receptor Knockout Mice
Prolyl hydroxylase domain 2 protein is a strong prognostic marker in human gastric cancer
Structure‐Activity Relationship and Crystallographic Studies on 4‐Hydroxypyrimidine HIF Prolyl Hydroxylase Domain Inhibitors
Use of cyclic peptides to induce crystallization: case study with prolyl hydroxylase domain 2
Prolyl-3-hydroxylase 1 in idiopathic pulmonary fibrosis
Cardiac functions of the cellular oxygen sensors prolyl-4-hydroxylase domain enzymes 2 and 3
The role of hif prolyl hydroxylases (PHD-2 and PHD-4) in tumor progression
Prolyl hydroxylase inhibition prevents graft injury during liver transplantation
Molecular exploration of natural and synthetic compounds databases for promising hypoxia inducible factor (HIF) Prolyl-4- hydroxylase domain (PHD) inhibitors using molecular simulation and free energy calculations
Prolyl hydroxylase domain inhibitor is an effective pre-hospital pharmaceutical intervention for trauma and hemorrhagic shock